<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02563795</url>
  </required_header>
  <id_info>
    <org_study_id>ANK-42479</org_study_id>
    <nct_id>NCT02563795</nct_id>
  </id_info>
  <brief_title>Low Dose Spinal Anesthesia in Cesarean Surgery</brief_title>
  <official_title>Does the Reduction of Local Anesthetic Dose Provide Surgical Anesthesia While Avoiding Maternal Hypotension in Obese Pregnant for C/S by Single Shot Spinal Anesthesia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia for cesarean section requires special importance because it may affect both mother
      and the baby. To avoid maternal hypotension related to spinal anesthesia must be the primary
      objective during anesthesia. Even though many factors influence sensory nerve block for
      surgical anesthesia, local anesthetic dose is the main determinant. Another factor that
      influence the sensory nerve block is the obesity related to pregnancy. Due to the enlargement
      of epidural venous plexus related to pregnancy, the subarachnoid and epidural space reduces,
      so the local anesthetic requirement also reduces. Many investigators recommend lower dose of
      local anesthetic in obese patients due to reduced requirement There are many studies about
      dose regimens for cesarean anesthesia, but ideal dose have not been found. Investigators have
      designed this study to see the effects of conventional dose (10 mg bupivacaine) vs. low dose
      plus fentanyl (7,5 mg bupivacaine+25 mcg fentanyl) in obese and normal weight pregnant for
      cesarean section. The hypothesis was: the low dose regimen provides surgical anesthesia in
      obese patients while avoiding maternal hypotension.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>VAS score &lt; 6 with only spinal anesthesia</measure>
    <time_frame>Approximately 30 min, during surgery</time_frame>
    <description>Achieving surgical anesthesia with low dose spinal anesthesia in obese pregnants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal hypotension</measure>
    <time_frame>Approximately 30 min, during surgery</time_frame>
    <description>Avoiding maternal hypotension</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Maternal Hypotension</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <description>Pregnant with BMI&lt;30 and having spinal anesthesia with 10 mg hyperbaric bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <description>Pregnant with BMI&lt;30 and having spinal anesthesia with 7,5 mg hyperbaric bupivacaine+25 mcg fentanyl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <description>Pregnant with BMI&gt;30 and having spinal anesthesia with 10 mg hyperbaric bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IV</arm_group_label>
    <description>Pregnant with BMI&gt;30 and having spinal anesthesia with 7,5 mg hyperbaric bupivacaine+25 mcg fentanyl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>To compare low dose spinal anesthesia with bupivacaine alone if it can maintain surgical anesthesia during cesarean section in obese and non-obese pregnants</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group III</arm_group_label>
    <other_name>Fentanyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>To compare low dose spinal anesthesia with bupivacaine+ fentanyl alone if it can maintain surgical anesthesia during cesarean section in obese and non-obese pregnants</description>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_label>Group IV</arm_group_label>
    <other_name>Bupivacaine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cesarean section under spinal anesthesia in obstetric clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant patients

        Exclusion Criteria:

          -  Spinal anesthesia contraindications, thrombocytopenia, coagulation defects,
             cardiomyopathy, placenta previa, twin pregnancy, hypersensitivity to amide local
             anesthetics or fentanyl, infection at the injection site, neurologic disease.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CIGDEM YILDIRIM GUCLU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cigdem Yildirim Guclu</name>
      <address>
        <city>Ankara</city>
        <zip>06550</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2015</study_first_submitted>
  <study_first_submitted_qc>September 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2015</study_first_posted>
  <last_update_submitted>March 14, 2016</last_update_submitted>
  <last_update_submitted_qc>March 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>CIGDEM YILDIRIM GUCLU</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Cesarean</keyword>
  <keyword>Maternal hypotension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

